ImmPACT Bio USA, Inc. ("ImmPACT BIO"), a clinical-stage company developing transformative logic-gate-based chimeric antigen receptor (CAR) T-cell therapies for treating cancer and autoimmune...

Opus IVS™, offering an integrated platform of OE and multi-brand diagnostics, remote programming, and calibration solutions, anchored by expert technicians and cutting-edge patented technology,...

New preclinical data presented at CTAD demonstrates exciting potential for a new drug approach for Alzheimer's disease, reducing brain tau pathology by ~70% CAMBRIDGE, Mass., Oct. 30, 2023...

BioMendics LLC, a pharmaceutical company developing new medicines to improve the lives of patients living with rare skin diseases, today announced its participation in the 7th Annual Dermatology...

The COP process must succeed and deliver, COP28 President Dr. Sultan Al Jaber stressed. "We have to come through. We must unite. We must act. And we must deliver in Dubai," he told delegates at...